緑内障手術器具市場（2020年）：2019年から2025年までの世界分析

当レポートは、緑内障手術器具市場について調査しており、COVID-19の影響、市場の動向やシェア、販売と売上予測・推計、戦略など市場の包括的な分析を提供しています。

プロセス

• 世界の疾患人口と人口統計モデル
• 財務報告の分析
• 眼科学調査、ビジネスニュース、およびその他の活動に焦点を当てた報道
• 世界的な眼科会議への出席と参加
• 企業の幹部および開業医との面接および関係

The new "2020 Glaucoma Surgical Device Market Report" provides an analysis of COVID-19 impact on 2020 sales and expected recovery in 2021 and through 2025. The report focuses on next-generation MIGS that target the suprachoroidal drainage space and characterizes a recent trend toward surgical device mix-and-match strategies to achieve trab-like low IOP outcomes.

It also tracks the progress being made in sustained drug delivery devices, adds a listing of 14 early-stage glaucoma surgery development projects, and describes the impact of just-approved MIGS designed for later stages of glaucoma.

The "2020 Glaucoma Surgical Device Market Report" offers a comprehensive analysis of the 2020 global market for glaucoma devices, as well as a discussion of important trends and key factors shaping future success. The report covers prevalence and forecasts for glaucoma worldwide and discusses the ophthalmologists who treat glaucoma. It also examines the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes. Product demand is forecast in units and dollars, and market shares are analyzed by product category.

Coverage includes:

• Background information about glaucoma, glaucoma populations, and glaucoma diagnosis.

• Estimates of current sales and sales forecasts for glaucoma devices, including average prices and total revenue.

• Profiles of prospective device buyers, including ophthalmologists, ophthalmic specialists, and ptometrists.

• Current reimbursement rates. Five basic surgery categories divided into 15 different product types, which are profiled.

• New section on key opinion leaders' decision making on glaucoma surgery options.

• Analysis of COVID-19 impact on 2020 sales and expected recovery in 2021 and through 2025.

• Tracking of the progress being made in sustained drug delivery devices in a separate section of the report.

Market Scope has prepared this report for members of the ophthalmic industry, market analysts, ophthalmologists, investors, and any others who are interested in the glaucoma device business or related products.

Our Process

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house analysts with over 100 years of collective ophthalmic market research experience. Each data point is driven by a combination of sources, including:

• Our proprietary global disease population and demographic models

• Analysis of company-published financial reports

• Focused coverage of ophthalmic scientific research, business news, and other activities

• Attendance and participation in worldwide ophthalmic meetings

• Interviews and relationships with company executives and practicing physicians